Home › Funds › CAUSEWAY CAPITAL MANAGEMENT LLC › AZN

CAUSEWAY CAPITAL MANAGEMENT LLC position in AZN

ASTRAZENECA PLC · Health Care

CAUSEWAY CAPITAL MANAGEMENT LLC reported holding 11,024,422 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$1.80B, representing 20.20% of its reported portfolio and ranking #1 among its reported holdings. CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)11.02M sh
Reported value held$1.80B
Portfolio Weight20.20%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAUSEWAY CAPITAL MANAGEMENT LLC's AZN position evolved

CAUSEWAY CAPITAL MANAGEMENT LLC first disclosed a stake in AZN in Q3 2023 at 355,221 shares (US$24.1M). The position peaked in Q3 2026 at 11,024,422 shares, worth US$1.80B. Across 13 filings, CAUSEWAY CAPITAL MANAGEMENT LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 11,024,422 shares valued at US$1.80B — an increase of 1,667,032 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2023 (shares rose 2% over the following quarter), a 70% increase in Q4 2024 (shares rose 14% over the following quarter), a 634% increase in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 355.22K $24.06M New
Q4 2023 460.72K $31.03M Add
Q1 2024 496.48K $33.64M Add
Q2 2024 450.59K $35.14M Reduce
Q3 2024 490.44K $38.21M Add
Q4 2024 831.87K $54.50M Add
Q1 2025 857.89K $63.05M Add
Q2 2025 953.45K $66.63M Add
Q3 2025 1.07M $81.89M Add
Q4 2025 1.01M $92.93M Reduce
Q1 2026 7.42M $1.44B Add
Q2 2026 9.36M $1.75B Add
Q3 2026 11.02M $1.80B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 64 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has CAUSEWAY CAPITAL MANAGEMENT LLC held AZN?

CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAUSEWAY CAPITAL MANAGEMENT LLC's current position in AZN?

As of Q3 2026, CAUSEWAY CAPITAL MANAGEMENT LLC holds 11.02M shares of AZN (ASTRAZENECA PLC), valued at $1.80B, representing 20.20% of its reported portfolio and ranking #1.

Has CAUSEWAY CAPITAL MANAGEMENT LLC been buying or selling AZN?

In the latest 13F filing (Q3 2026), CAUSEWAY CAPITAL MANAGEMENT LLC increased its position in AZN. The position peaked in Q3 2026 at 11.02M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.